Breakthrough in ovarian cancer: Selumetinib

Researchers have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/A...